p300/CBP inhibition enhances the efficacy of programmed death-ligand 1 blockade treatment in prostate cancer

Jinghui Liu, Daheng He, Lijun Cheng, Changkun Huang, Yanquan Zhang, Xiongjian Rao, Yifan Kong, Chaohao Li, Zhuangzhuang Zhang, Jinpeng Liu, Karrie L. Jones, Dana Napier, Eun Y. Lee, Chi Wang, Xiaoqi Liu